
Ensign Group (ENSG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.2B
Gross Profit
198.8M
16.19%
Operating Income
103.9M
8.46%
Net Income
84.5M
6.88%
EPS (Diluted)
$1.44
Balance Sheet Metrics
Total Assets
4.8B
Total Liabilities
2.8B
Shareholders Equity
1.9B
Debt to Equity
1.47
Cash Flow Metrics
Operating Cash Flow
97.9M
Free Cash Flow
29.3M
Revenue & Profitability Trend
Ensign Group Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.3B | 3.7B | 3.0B | 2.6B | 2.4B |
Cost of Goods Sold | 3.6B | 3.1B | 2.5B | 2.2B | 2.0B |
Gross Profit | 667.6M | 590.8M | 518.0M | 468.2M | 407.5M |
Gross Margin % | 15.7% | 15.8% | 17.1% | 17.8% | 17.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 225.1M | 263.0M | 158.8M | 151.8M | 129.7M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 225.1M | 263.0M | 158.8M | 151.8M | 129.7M |
Operating Income | 358.3M | 255.4M | 296.8M | 260.5M | 223.2M |
Operating Margin % | 8.4% | 6.8% | 9.8% | 9.9% | 9.3% |
Non-Operating Items | |||||
Interest Income | 28.7M | - | - | 4.4M | 3.8M |
Interest Expense | 8.3M | 8.1M | 8.9M | 6.8M | 9.4M |
Other Non-Operating Income | 7.3M | 25.5M | 1.2M | 4.4M | - |
Pre-tax Income | 386.1M | 272.8M | 289.1M | 258.0M | 217.6M |
Income Tax | 87.6M | 62.9M | 64.4M | 60.3M | 46.2M |
Effective Tax Rate % | 22.7% | 23.1% | 22.3% | 23.4% | 21.3% |
Net Income | 298.5M | 209.8M | 224.7M | 197.7M | 171.4M |
Net Margin % | 7.0% | 5.6% | 7.4% | 7.5% | 7.1% |
Key Metrics | |||||
EBITDA | 478.5M | 353.2M | 360.4M | 320.8M | 281.5M |
EPS (Basic) | $5.26 | $3.76 | $4.09 | $3.57 | $3.19 |
EPS (Diluted) | $5.12 | $3.65 | $3.95 | $3.42 | $3.06 |
Basic Shares Outstanding | 56655000 | 55708000 | 54887000 | 54486000 | 53434000 |
Diluted Shares Outstanding | 56655000 | 55708000 | 54887000 | 54486000 | 53434000 |
Income Statement Trend
Ensign Group Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 464.6M | 509.6M | 316.3M | 262.2M | 236.6M |
Short-term Investments | 62.3M | 17.2M | 15.4M | 13.8M | 13.4M |
Accounts Receivable | 569.9M | 485.0M | 408.4M | 328.7M | 305.1M |
Inventory | - | - | - | - | - |
Other Current Assets | 60.9M | 35.0M | 41.0M | 29.6M | - |
Total Current Assets | 1.2B | 1.0B | 781.1M | 639.7M | 583.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.3B | 2.1B | 1.7B | 1.4B | 1.3B |
Goodwill | 203.3M | 160.3M | 160.2M | 127.3M | 115.6M |
Intangible Assets | 7.3M | 6.5M | 6.4M | 6.4M | 6.6M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 112.8M | 104.7M | 74.4M | 60.1M | 53.3M |
Total Non-Current Assets | 3.5B | 3.1B | 2.7B | 2.2B | 2.0B |
Total Assets | 4.7B | 4.2B | 3.5B | 2.9B | 2.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 98.9M | 92.8M | 77.1M | 58.1M | 50.9M |
Short-term Debt | 97.6M | 86.5M | 69.7M | 55.9M | 51.1M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | 102.0M |
Total Current Liabilities | 743.4M | 734.7M | 582.1M | 523.1M | 562.4M |
Non-Current Liabilities | |||||
Long-term Debt | 1.9B | 1.8B | 1.5B | 1.2B | 1.1B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 64.2M | 49.4M | 33.3M | 27.1M | 39.7M |
Total Non-Current Liabilities | 2.1B | 1.9B | 1.6B | 1.3B | 1.2B |
Total Liabilities | 2.8B | 2.7B | 2.2B | 1.8B | 1.7B |
Equity | |||||
Common Stock | 61.0K | 60.0K | 59.0K | 58.0K | 58.0K |
Retained Earnings | 1.4B | 1.1B | 946.3M | 734.0M | 551.1M |
Treasury Stock | 117.8M | 116.6M | 114.6M | 83.0M | 71.2M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.8B | 1.5B | 1.2B | 1.0B | 818.2M |
Key Metrics | |||||
Total Debt | 2.0B | 1.9B | 1.6B | 1.3B | 1.1B |
Working Capital | 414.2M | 312.2M | 199.1M | 116.6M | 20.6M |
Balance Sheet Composition
Ensign Group Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 298.5M | 209.8M | 224.7M | 197.7M | 171.4M |
Depreciation & Amortization | 84.1M | 72.4M | 62.4M | 56.0M | 54.6M |
Stock-Based Compensation | 36.2M | 30.8M | 22.7M | 18.7M | 14.5M |
Working Capital Changes | -80.2M | -70.5M | -88.4M | -53.6M | 7.9M |
Operating Cash Flow | 338.1M | 265.0M | 222.1M | 220.8M | 270.8M |
Investing Activities | |||||
Capital Expenditures | -158.2M | -106.2M | -87.5M | -69.6M | -49.9M |
Acquisitions | -156.5M | 0 | -16.4M | -8.0M | 0 |
Investment Purchases | -105.1M | -29.6M | -22.0M | -32.3M | -21.7M |
Investment Sales | 26.4M | 18.9M | 14.4M | 27.5M | 24.5M |
Investing Cash Flow | -390.1M | -182.7M | -186.2M | -173.8M | -58.7M |
Financing Activities | |||||
Share Repurchases | -1.2M | -1.9M | -31.6M | -11.8M | -25.9M |
Dividends Paid | -13.7M | -12.9M | -12.2M | -11.5M | -10.8M |
Debt Issuance | 400.0K | 150.0K | 411.0K | 45.2M | 417.2M |
Debt Repayment | -4.4M | -4.0M | -4.1M | -3.1M | -629.7M |
Financing Cash Flow | -24.4M | -19.0M | -44.9M | -43.2M | -362.5M |
Free Cash Flow | 188.9M | 270.5M | 185.0M | 206.0M | 323.0M |
Net Change in Cash | -76.4M | 63.3M | -9.0M | 3.9M | -150.4M |
Cash Flow Trend
Ensign Group Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.66
Forward P/E
27.56
Price to Book
4.80
Price to Sales
2.12
PEG Ratio
1.76
Profitability Ratios
Profit Margin
7.00%
Operating Margin
8.46%
Return on Equity
17.54%
Return on Assets
5.30%
Financial Health
Current Ratio
1.41
Debt to Equity
100.93
Beta
1.02
Per Share Data
EPS (TTM)
$5.52
Book Value per Share
$35.23
Revenue per Share
$80.96
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ensg | 9.8B | 30.66 | 4.80 | 17.54% | 7.00% | 100.93 |
HCA Healthcare | 94.6B | 16.99 | -77.25 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.15 | 4.18 | 29.65% | 7.18% | 158.70 |
DaVita | 9.8B | 13.55 | 6.86 | 57.94% | 6.35% | 825.19 |
Chemed | 6.6B | 23.36 | 5.50 | 24.14% | 11.56% | 12.15 |
Option Care Health | 4.7B | 22.81 | 3.43 | 15.25% | 3.93% | 90.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.